6-Mercaptopurine-induced histopathological changes and xanthine oxidase expression in rat placenta

Journal of Toxicological Sciences

Volumn 37, Issue 3, 2012, Pages 607-615

  Taki, Kenji ^a,b   Fukushima, Tamio ^a,c   Ise, Ryota ^a,d   Horii, Ikuo ^a,b   Yoshida, Takemi ^a  

^a SHOWA UNIVERSITY   (Japan)

^b PFIZER INC   (United States)

^c SHIONOGI AND CO LTD   (Japan)

^d SHIN NIPPON BIOMEDICAL LABORATORIES LTD   (Japan)

Author keywords

6 mercaptopurine; Placenta; Rat; Xanthine oxidase

Indexed keywords

CASPASE 3; GLYCOGEN; MERCAPTOPURINE; XANTHINE OXIDASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOLYSIS; EMBRYO DEVELOPMENT; FEMALE; GIANT CELL; NONHUMAN; PLACENTA; PLACENTA DEVELOPMENT; PREGNANCY; PROTEIN EXPRESSION; RAT; SPONGIOTROPHOBLAST; TROPHOBLAST;

RATTUS;

EID: 84863110084     PISSN: 03881350     EISSN: 18803989     Source Type: Journal    
DOI: 10.2131/jts.37.607     Document Type: Article

References (27)

1. Amemiya, K., Keen, C.L. and Hurley, L.S. (1986): 6-Mercaptopurine-induced alterations in mineral metabolism and teratogenesis in the rat. Teratology, 34, 321-334.
2. Blackburn, M.R., Knudsen, T.B. and Kellems, R.E. (1997): Genetically engineered mice demonstrate that adenosine deaminase is essential for early postimplantation development. Development, 124, 3089-3097.
3. Bragonier, J.R. and Carver, M.J. (1968): The influence of 6-mercaptopurine on rat placenta and fetus. Biochem. Pharmacol., 17, 1689-1697.
4. Bragonier, J.R., Roesky, N. and Carver, M.J. (1964): Teratogenesis: Effects of Substituted Purines and the Influence of 4-Hydroxypyrazolopyrimidine in the Rat. Proc. Soc. Exp. Biol. Med., 116, 685-688.
5. Chan, S.W. and Leathem, J.H. (1975): Placental steroidogenesis in the rat: progesterone production by tissue of the basal zone. Endocrinology, 96, 298-303.
6. Dickson, A.D. and Bulmer, D. (1960): Observations on the placental giant cells of the rat. J. Anat., 94, 418-424.
7. Estlin, E.J. (2001): Continuing therapy for childhood acute lymphoblastic leukaemia: clinical and cellular pharmacology of methotrexate, 6-mercaptopurine and 6-thioguanine. Cancer Treat. Rev., 27, 351-363.
8. Furukawa, S., Usuda, K., Abe, M., Hayashi, S. and Ogawa, I. (2007): Busulfan-induced apoptosis in rat placenta. Exp. Toxicol. Pathol., 59, 97-103.
9. Furukawa, S., Usuda, K., Abe, M., Hayashi, S. and Ogawa, I. (2008): Effect of 6-mercaptopurine on rat placenta. J. Vet. Med. Sci., 70, 551-556.
10. Hassoun, P.M., Yu, F.S., Shedd, A.L., Zulueta, J.J., Thannickal, V.J., Lanzillo, J.J. and Fanburg, B.L. (1994): Regulation of endothelial cell xanthine dehydrogenase xanthine oxidase gene expression by oxygen tension. Am. J. Physiol., 266, L163-171.
11. Hossain, M.M., Nakayama, H. and Goto, N. (1995): Apoptosis in the central nervous system of developing mouse fetuses from 5-azacytidine-administered dams. Toxicol. Pathol., 23, 367-372.
12. Katayama, K., Ueno, M., Takai, H., Ejiri, N., Uetsuka, K., Nakayama, H. and Doi, K. (2002): Ethylnitrosourea induces apoptosis and growth arrest in the trophoblastic cells of rat placenta. Biol. Reprod., 67, 431-435.
13. Livak, K.J. and Schmittgen, T.D. (2001): Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T) Method. Methods., 25, 402-408.
14. Lupidi, G., Marmocchi, F. and Cristalli, G. (1998): Inhibition studies on membrane adenosine deaminase from human placenta. Biochem. Mol. Biol. Int., 46, 1071-1080.
15. Pacher, P., Nivorozhkin, A. and Szabo, C. (2006): Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol. Pharmacol. Rev., 58, 87-114.
16. Parks, D.A. and Granger, D.N. (1986): Xanthine oxidase: biochemistry, distribution and physiology. Acta. Physiol. Scand. Suppl., 548, 87-99.
17. Platzek, T., Schwabe, R., Rahm, U. and Bochert, G. (1994): DNA modification induced by 6-mercaptopurine riboside in murine embryos. Chem. Biol. Interact., 93, 59-71.
18. Pritsos, C.A. (2000): Cellular distribution, metabolism and regulation of the xanthine oxidoreductase enzyme system. Chem. Biol. Interact., 129, 195-208.
19. Rousseaux, C.G. and Schiefer, H.B. (1987): Maternal toxicity, embryolethality and abnormal fetal development in CD-1 mice following one oral dose of T-2 toxin. J. Appl. Toxicol., 7, 281-288.
20. Saarikoski, S. and Seppala, M. (1973): Immunosuppression during pregnancy: transmission of azathioprine and its metabolites from the mother to the fetus. Am. J. Obstet. Gynecol., 115, 1100-1106.
21. Shoro, A.A. (1981): Correlation between the placental and fetal body weight and size of the rat fetuses affected by intra-uterine administration of neuromuscular blocking agents. Methods. Find. Exp. Clin. Pharmacol., 3, 149-154.
22. Shrader, R.E., Hirsch, K.S., Levin, J. and Hurley, L.S. (1978): Attenuating effect of zinc on abnormal placental morphology in 6-mercaptopurine treated rats. Teratology, 17, 315-325.
23. Soares, M.J., Faria, T.N., Roby, K.F. and Deb, S. (1991): Pregnancy and the prolactin family of hormones: coordination of anterior pituitary, uterine, and placental expression. Endocr. Rev., 12, 402-423.
24. Tanaka, M., Natori, M., Ishimoto, H., Miyazaki, T., Kobayashi, T. and Nozawa, S. (1994): Experimental growth retardation produced by transient period of uteroplacental ischemia in pregnant Sprague-Dawley rats. Am. J. Obstet. Gynecol., 171, 1231-1234.
25. Watson, E.D. and Cross, J.C. (2005): Development of structures and transport functions in the mouse placenta. Physiology (Bethesda)., 20, 180-193.
26. Yamauchi, H., Katayama, K., Yasoshima, A., Uetsuka, K., Nakayama, H. and Doi, K. (2003): 1-β-D-arabinofuranosylcytosine (Ara-C)-induced apoptosis in the rat fetal tissues and placenta. J. Toxicol. Pathol., 16, 223-229.
27. Zimm, S., Collins, J.M., O'Neill, D., Chabner, B.A. and Poplack, D.G. (1983): Inhibition of first-pass metabolism in cancer chemotherapy: interaction of 6-mercaptopurine and allopurinol. Clin. Pharmacol. Ther., 34, 810-817.